ES2052942T3 - Regulador biologico extraido de gingko biloba, activo en diversas patologias. - Google Patents
Regulador biologico extraido de gingko biloba, activo en diversas patologias.Info
- Publication number
- ES2052942T3 ES2052942T3 ES89401191T ES89401191T ES2052942T3 ES 2052942 T3 ES2052942 T3 ES 2052942T3 ES 89401191 T ES89401191 T ES 89401191T ES 89401191 T ES89401191 T ES 89401191T ES 2052942 T3 ES2052942 T3 ES 2052942T3
- Authority
- ES
- Spain
- Prior art keywords
- bioparyl
- gingko biloba
- ribonucleose
- active
- fibrosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicinal Preparation (AREA)
Abstract
BIOPARYL ES OBTENIDO POR UN NUEVO PROCESO DE EXTRACCION HIDROLITICA SEGUIDO DE PURIFICACIONES APLICADAS A LAS HOJAS DE OTOÑO DEL ARBOL GINGKO BILOBA. BIOPARYL JUEGA UN PAPEL IMPORTANTE COMO REGULADOR DE LA ACTIVIDAD DE CIERTAS ENZIMAS, RIBONUCLEOSAS EN PARTICULAR, ENZIMAS IMPLICADAS EN EL MECANISMO FUNDAMENTAL DE LA EXPRESION DE LOS GENES. NO POSEE EFECTO TOXICO NI EFECTO SECUNDARIO EN EL MAMIFERO SANO Y PUEDE SER UTILIZADO PARA MEJORAR VARIAS CONDICIONES PATOLOGICAS. BIOPARYL ES EFICAZ EN LA PREVENCION Y LA REVERSION DE LA FIBROSIS DE DIVERSOS TEJIDOS, FIBROSIS ENGENDRADA POR LAS RADIACIONES O POR AGENTES QUIMICOS. REBAJA LA TASA ANORMALMENTE ELEVADA DE GAMMAGLOBULINAS E INMUNOGLOBULINAS ENTRE LOS ENFERMOS DE INFLAMACION O DE ENFERMEDADES AUTO-INMUNES, INCLUYENDO EL SINDROME DE INMUNODEFICIENCIA (SIDA). ENTRE LOS LEUCEMICOS O DE CANCERES SOLIDOS, BIOPARYL NORMALIZA LAS RIBONUCLEOSAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809738A FR2634380B1 (fr) | 1988-07-19 | 1988-07-19 | Regulateur biologique, actif dans diverses pathologies |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2052942T3 true ES2052942T3 (es) | 1994-07-16 |
Family
ID=9368543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89401191T Expired - Lifetime ES2052942T3 (es) | 1988-07-19 | 1989-04-26 | Regulador biologico extraido de gingko biloba, activo en diversas patologias. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0352146B1 (es) |
JP (1) | JPH0278628A (es) |
CA (1) | CA1337177C (es) |
DE (1) | DE68903065T2 (es) |
DK (1) | DK355089A (es) |
ES (1) | ES2052942T3 (es) |
FR (1) | FR2634380B1 (es) |
GR (1) | GR3006687T3 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3832056A1 (de) * | 1988-09-21 | 1990-03-22 | Scholle Helmut Dr Med | Verwendung eines ginkgo-extraktes |
DE4030758A1 (de) * | 1990-09-28 | 1992-04-02 | Schwabe Willmar Gmbh & Co | Extrakt aus blaettern von ginkgo biloba, insbesondere zur intravenoesen injektion oder infusion, verfahren zu seiner herstellung und den extrakt enthaltende ampullenpraeparate |
DE4308443C2 (de) * | 1993-03-17 | 1996-09-19 | Laves Hans Georg | Arzneimittel zur Behandlung von Retrovirusinfektionen |
FR2754714B1 (fr) * | 1996-10-22 | 1999-01-22 | Roc Sa | Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba |
FR2759371B1 (fr) * | 1997-02-07 | 1999-03-19 | Bio Merieux | Utilisation d'un polypeptide, pour obtenir une composition pour detecter, prevenir ou traiter une maladie degenerative et/ou auto-immune |
US6030621A (en) * | 1998-03-19 | 2000-02-29 | De Long; Xie | Ginkgo biloba composition, method to prepare the same and uses thereof |
WO2002011745A1 (en) * | 2000-08-04 | 2002-02-14 | Angiolab, Inc. | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase |
KR100417172B1 (ko) * | 2000-08-04 | 2004-02-05 | 주식회사 안지오랩 | 은행엽 엑스를 유효성분으로 하는 혈관신생 억제제 |
FR2911782A1 (fr) * | 2007-01-31 | 2008-08-01 | Jacqueline Martin | Comment guerir du sida avec mentha pulegium et ginkgo biloba |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2117429C3 (de) * | 1971-04-08 | 1982-04-01 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Verfahren zur Herstellung eines Injektions- bzw. Infusionspräparates mit einem Gehalt an einem Wirkstoffgemisch aus den Blättern von Ginkgo biloba |
FR2518406A1 (fr) * | 1981-12-22 | 1983-06-24 | Prodipharm | Nouveau procede d'obtention de substances vaso-actives extraites de feuilles de ginkgo |
-
1988
- 1988-07-19 FR FR8809738A patent/FR2634380B1/fr not_active Expired - Lifetime
-
1989
- 1989-04-26 ES ES89401191T patent/ES2052942T3/es not_active Expired - Lifetime
- 1989-04-26 EP EP89401191A patent/EP0352146B1/fr not_active Expired - Lifetime
- 1989-04-26 DE DE8989401191T patent/DE68903065T2/de not_active Expired - Fee Related
- 1989-06-22 CA CA000603639A patent/CA1337177C/en not_active Expired - Fee Related
- 1989-07-18 DK DK355089A patent/DK355089A/da not_active Application Discontinuation
- 1989-07-19 JP JP1184843A patent/JPH0278628A/ja active Pending
-
1992
- 1992-12-28 GR GR920403150T patent/GR3006687T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE68903065D1 (de) | 1992-11-05 |
FR2634380A1 (fr) | 1990-01-26 |
EP0352146A1 (fr) | 1990-01-24 |
JPH0278628A (ja) | 1990-03-19 |
GR3006687T3 (es) | 1993-06-30 |
DK355089A (da) | 1990-01-20 |
EP0352146B1 (fr) | 1992-09-30 |
FR2634380B1 (fr) | 1990-10-12 |
DE68903065T2 (de) | 1993-03-25 |
CA1337177C (en) | 1995-10-03 |
DK355089D0 (da) | 1989-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188595T3 (es) | Derivados del acido 1-(2-oxo-acetil)-piperidin-2-carboxilico como sensibilizadores de celulas cancerosas resistentes a multiples farmacos. | |
CY1106798T1 (el) | Ανθρωπινα μεσεγχυματικα βλαστοκυτταρα απο περιφερειακο αιμα | |
ES2052942T3 (es) | Regulador biologico extraido de gingko biloba, activo en diversas patologias. | |
Horwath-Winter et al. | Iodide iontophoresis as a treatment for dry eye syndrome | |
Plasmeijer et al. | Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance–the impact of immunosuppression on frequency of cSCC | |
ES2063011T3 (es) | Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente. | |
DE3752112D1 (de) | Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen | |
ES2065369T3 (es) | Uso de bencimidazoles en el tratamiento de enfermedades epiteliales. | |
PT92821A (pt) | Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa | |
ATE189393T1 (de) | Therapeutisches agens zur wundbehandlung | |
Reisi et al. | Effects of treadmill running on short-term pre-synaptic plasticity at dentate gyrus of streptozotocin-induced diabetic rats | |
EA200100342A1 (ru) | Связывающие соединения адгезионной молекулы нервной клетки | |
DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
ES2162331T3 (es) | Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea. | |
AR002272A1 (es) | Uso de amidas de fenilciclohexilcarboxilicos | |
ATE246929T1 (de) | Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen | |
TR200103004T2 (tr) | Pirolidinkarbonilamino siklik disülfitler. | |
ES2118726T3 (es) | Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos. | |
ATE113209T1 (de) | Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten. | |
ES2129893T3 (es) | Dinucleosido-5',5'-pirofosfatos. | |
Zhao et al. | Radiation-induced up-regulation of Mmp2 involves increased mRNA stability, redox modulation, and MAPK activation | |
IT7826263A0 (it) | Derivati del piranocromone e composizione terapeutica comprendente gli stessi, per il trattamento di malattie allergiche. | |
Katiyar et al. | Pathology of inflammatory‐reparative response in punched wounds of the chicken skin | |
Das et al. | Modification of cytotoxic effects of inorganic arsenic by a crude extract of Allium sativum L. in mice | |
NO954081L (no) | Cytotoksisk faktor forbundet med disseminert sklerose, dens påvisning og kvantifisering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 352146 Country of ref document: ES |